Alleviating Osteoporosis
Manchester Scientists Challenge the Disease
Osteoporosis is a devastating disease that causes brittle and fragile bones in its sufferers. It affects a large proportion of the population; one in three women and one in ten men over the age of fifty. It alters the quality of life of its sufferers, from walking difficulties to the inability to lift objects.
A team of scientists at the University of Manchester??s School of Bioscience is currently developing a treatment to alleviate the symptoms and life-devastating effects of the disease.
The drug is called thiazide diuretic and is currently used to treat patients with high blood pressure. However, the drug can also be used to promote the formation of new bone.
The School of Biosciences has been awarded a grant of ??90 000 from the Arthritis Research Campaign to cover the two year medical research project.
The work of the Manchester-based scientists will help sufferers of Osteoporosis world wide.
Submitted by: Shelley Deasey, 13 December 2004
